Movement abnormalities and psychotic-like experiences in childhood: Markers of developing schizophrenia?

Psychological Medicine

Volumn 42, Issue 1, 2012, Pages 99-109

  MacManus, D ^a   Laurens, K R ^a,b,c   Walker, E F ^d   Brasfield, J L ^d   Riaz, M ^a   Hodgins, S ^a,e,f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antecedents; dopamine; dyskinesia; psychosis; risk factors

Indexed keywords

DOPAMINE;

ARTICLE; CHILD; CONTROL; CORPUS STRIATUM; DEVELOPMENTAL DISORDER; DYSKINESIA; FEMALE; HUMAN; MALE; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGIC TEST; PSYCHOLOGY; PSYCHOSIS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ISOLATION; UNITED KINGDOM; URBAN POPULATION; VIDEORECORDING;

CHILD; CORPUS STRIATUM; DEVELOPMENTAL DISABILITIES; DOPAMINE; DYSKINESIAS; FEMALE; GREAT BRITAIN; HUMANS; INTERNAL-EXTERNAL CONTROL; INTERVIEW, PSYCHOLOGICAL; MALE; PSYCHOSOCIAL DEPRIVATION; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RISK FACTORS; ROC CURVE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; URBAN POPULATION; VIDEO RECORDING;

EID: 82555194499     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711001085     Document Type: Article

References (75)

1. Alexander GE, Crutcher MD, DeLong MR (1991). Basal ganglia- thalamocortical circuits: parallel substrates for motor, oculomotor, ' prefrontal ' and ' limbic ' functions. Progressive Brain Research 86, 119-145.
2. Angold A, Weissman MM, John K, Merikancas KR, Prusoff BA, Wickramaratne P, Gammon GD, Warner V (1987). Parent and child reports of depressive symptoms in children at low and high risk of depression. Journal of Child Psychology and Psychiatry 28, 901-915. (Pubitemid 18044812)
3. Asnarow JR (1988). Children at risk for schizophrenia: converging lines of evidence. Schizophrenia Bulletin 14, 613-631.
4. Boks MP, Liddle PF, Burgerhof JGM, Knegtering R, Van Den Bosch RJ (2004). Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica 110, 29-35. (Pubitemid 38822645)
5. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, Poulton R (2002). Evidence for earlychildhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry 59, 449-456. (Pubitemid 34477681)
6. Cannon TD, van Erp TGM, Rosso IM, Huttunen M, Lönnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen V, Standertskjöld-Nordenstam C (2002). Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Archives of General Psychiatry 59, 35-41. (Pubitemid 34044403)
7. Cassady SL, Adami H, Moran DC (1998). Spontaneous dyskinesia in patients with schizophrenia spectrum personality. American Journal of Psychiatry 155, 70-75. (Pubitemid 28037551)
8. Cohen JD (2002). Neural networks of prefrontal cortex and cognitive control. In: Handbook of Neuropsychology, 2nd edn, vol 7 (ed. J Grafman). Elsevier Science.
9. Costello A, Edelbrock C, Kalas R, Kessler M, Klaric S (1982). NIMH Diagnostic Interview Schedule for Children: Child Version. National Institute of Mental Health: Rockville, MD.
10. Crow TJ, Done DJ, Sacker A (1995). Childhood precursors of psychosis as clues to its evolutionary origins. European Archives of Psychiatry and Clinical Neuroscience 245, 61-69.
11. Cullen AE, Dickson H, West SA, Morris RG, Mould GL, Hodgins S, Murray RM, Laurens KR (2010). Neurocognitive deficits in children aged 9-12 years who present putative antecedents of schizophrenia. Schizophrenia Research 121, 15-23.
12. Deakin JFW, Slater P, Simpson MDC, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ (1989). Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. Journal of Neurochemistry 52, 1781-1786. (Pubitemid 19140763)
13. D'Reaux R, Neumann CS, Rhymer K (2000). Time of day of testing and neuropsychological performance in schizophrenia patients and healthy controls. Schizophrenia Research 45, 157-167.
14. Dreher JC, Trapp W, Banquet JP, Keil M, Gunther W, Burnod Y (1999). Planning dysfunction in schizophrenia: impairment of potentials preceeding fixed/free and single/sequence of self-initiated finger movements. Experimental Brain Research 45, 157-167.
15. Edelbrock C, Costello AJ, Dulcan MK, Conover NC, Kala R (1986). Parent-child agreement on child psychiatric symptoms assessed via structured interview. Journal of Child Psychology and Psychiatry 27, 181-190. (Pubitemid 16142065)
16. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S (1992). Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. Archives of General Psychiatry 49, 221-235.
17. Goodman R (1997). The Strengths and Difficulties Questionnaire: a research note. Journal of Child Psychology and Psychiatry 38, 581-586. (Pubitemid 27341892)
18. Goodman R (2001). Psychometric properties of the Strengths and Difficulties Questionnaire. Journal of the American Academy of Child and Adolescent Psychiatry 40, 1337-1345. (Pubitemid 32995803)
19. Gottesman II, Erlenmeyer-Kimling L (2001). Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia. Schizophrenia Research 51, 93-102. (Pubitemid 32722074)
20. Hans SL, Auerbach JG, Auerbach AG, Marcus J (2005). Development from birth to adolescence of children at-risk for schizophrenia. Journal of Child and Adolescent Psychopharmacology 15, 384-394. (Pubitemid 41192826)
21. Hanssen M, Bak M, Bijl R, Vollebergh W, van Os J (2005). The incidence and outcome of subclinical psychotic experiences in the general population. British Journal of Clinical Psychology 44, 181-191. (Pubitemid 40873432)
22. Hoff JL, Van den Plas AA, Wagemans EA, Van Hilten JJ (2001). Accelerometric assessment of levo-dopa induced dyskinesias in Parkinson's disease. Movement Disorders 16, 58-61. (Pubitemid 36041114)
23. Howes O, Kapur S (2009). The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophrenia Bulletin 35, 549-562.
24. Howes O, Montgomery AJ, Asselin MC, Murray R, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 66, 13-20.
25. Hsaio CM, Lin KJ, Liu CY, Tzen KY, Yen TC (2003). Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1. Schizophrenia Research 65, 39-46.
26. Isohanni M, Jones PB, Moilanen K, Rantakallio P, Veijola J, Oja H, Koiranen M, Jokelainen J, Croudace T, Järvelin M (2001). Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 birth cohort. Schizophrenia Research 52, 1-19. (Pubitemid 32947043)
27. Isohanni M, Murray GK, Jokelain J, Croudace T, Jones PB (2004). The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophrenia Research 71, 213-225.
28. Jacobson S, Kelleher I, Harley M, Murtagh A, Clarke M, Blanchard M, Connolly C, O'Hanlon E, Garavan H, Cannon M (2010). Structural and functional brain correlates of subclinical psychotic symptoms in 11-13 year old schoolchildren. NeuroImage 49, 1875-1885.
29. Jones P, Murray R, Jones P, Rodgers B, Marmot M (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398-1402. (Pubitemid 24365314)
30. Kalachnik JE, Sprague RL (1993). The Dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut-off for the mentally ill and mentally retarded populations. Journal of Clinical Psychology 49, 177-189. (Pubitemid 23133553)
31. Kalachnik JE, Young RC, Offerman O (1989). A tardive dyskinesia evaluation and diagnosis form for applied facilities. Psychopharmacology Bulletin 20, 303-309.
32. Kelleher I, Cannon M (2011). Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychological Medicine 41, 1-6.
33. Kelleher I, Harley M, Lynch F, Arseneault L, Fitzpatrick C, Cannon M (2008). Associations between childhood trauma, bullying and psychotic symptoms among a school-based adolescent sample. British Journal of Psychiatry 193, 378-382.
34. Kelleher I, Harley M, Murtagh A, Cannon M (2011). Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophrenia Bulletin 37, 362-369.
35. Kestler LP, Walker E, Vega EM (2001). Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behavioural Pharmacology 12, 355-371. (Pubitemid 32983509)
36. Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML, Taylor EA (2007). Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. Schizophrenia Research 90, 130-146. (Pubitemid 46188519)
37. Laurens KR, Hodgins S, Mould GL, West SA, Schoenberg PL, Murray RM, Taylor EA (2010). Error-related processing dysfunction in children aged 9 to 12 years presenting putative antecedents of schizophrenia. Biological Psychiatry 67, 238-245.
38. Laurens KR, Hodgins S, Taylor EA, Murray RM (2011). Is earlier intervention for schizophrenia possible ?: Identifying antecedents of schizophrenia in children aged 9-12 years. In Schizophrenia: The Final Frontier. A Festschrift for Robin M. Murray (Maudsley Series) (ed. A. S. David, P. McGuffin and S. Kapur). Psychology Press: London.
39. Laurens KR, West SA, Murray RM, Hodgins S (2008). Psychotic-like experiences and other antecedents of schizophrenia in children aged 9-12 years: a comparison of ethnic and migrant groups in the United Kingdom. Psychological Medicine 38, 1103-1111. (Pubitemid 351950142)
40. Mangalore R, Knapp M (2007). Cost of schizophrenia in England. Journal of Mental Health Policy and Economics 10, 23-41. (Pubitemid 46613421)
41. Marcus J, Hans SL, Auerback JG (1993). Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioural deficits at school age. Archives of General Psychiatry 50, 797-809. (Pubitemid 23303101)
42. Marcus J, Hans SL, Lewow E, Wilinson L, Burack C (1985). Neurological findings in high-risk children: childhood assessment and 5-year followup. Schizophrenia Bulletin 11, 85-100.
43. Mink JW (2003). The basal ganglia and involuntary movements. Archives of Neurology 60, 1365-1368.
44. Mittal VA, Dhruv S, Tessner K, Walder D, Walker E (2007). Relation of neurological soft signs to psychiatric symptoms in schizophrenia. Biological Psychiatry 61, 1179-1186.
45. Mittal VA, Neumann C, Saczawa M, Walker E (2008). Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. Archives of General Psychiatry 65, 165-171. (Pubitemid 351214315)
46. Neumann CS, Grimes K, Walker EF, Baum K (1995). Developmental pathways to schizophrenia: behavioural subtypes. Journal of Abnormal Psychology 104, 558-66.
47. Owen F, Crow TJ, Poulter M, Cross AJ, Longden A, Riley GJ (1978). Increased dopamine-receptor sensitivity in schizophrenia. Lancet 312, 223-226.
48. Owens DG, Johnstone EC (1982). Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Archives of General Psychiatry 39, 452-461. (Pubitemid 12152814)
49. Papapetropoulos S, Mash DC (2005). Psychotic symptoms in Parkinson's disease: from description to etiology. Journal of Neurology 252, 753-764. (Pubitemid 40984849)
50. Pencina MJ, D'Agostino Sr RB, D'Agostino RB (2007). Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine 27, 157-172. (Pubitemid 351193639)
51. Polanczyk G, Moffitt TE, Arseneault L, Cannon M, Ambler A, Keefe RSE, Houts R, Odgers CL, Caspi A (2010). Etiological and clinical features of childhood psychotic symptoms. Archives of General Psychiatry 67, 328-338.
52. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray RM, Harrington H (2000). Children's self-report psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of General Psychiatry 57, 1053-1058.
53. Puri BK, Barnes TRE, Chapman MJ, Hutton SB, Joyce EM (1999). Spontaneous dyskinesia in first episode schizophrenia. Journal of Neurological and Neurosurgical Psychiatry 66, 76-78. (Pubitemid 29101493)
54. Reynolds GP (1983). Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305, 527-529. (Pubitemid 13009091)
55. Roessler W, Joachim Salize H, van Os J, Riecher-Rossler A (2005). Size of burden of schizophrenia and psychotic disorders. European Neuropsychopharmacology 15, 399-409. (Pubitemid 40943544)
56. Rosso IM, Bearden CE, Hollister JM, Gasperoni TL, Sanchez LE, Hadley T, Cannon TD (2000). Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophrenia Bulletin 26, 367-378. (Pubitemid 30423215)
57. Schiffman J, Walker E, Morten E, Schulsinger F, Sorensen H, Mednick S (2004). Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. American Journal of Psychiatry 161, 2021-2027. (Pubitemid 39441402)
58. Seeman P (1992). Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum: commentary on the current status of PET scanning with respect to schizophrenia. Neuropsychopharmacology 7, 55-57.
59. Seeman P, Kapur S (2000). Schizophrenia: more dopamine, more D2 receptors. Proceedings of the National Academy of Sciences of the USA 97, 7673-7675.
60. Siever LJ, Kalus OF, Keefe RS (1990a). Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal disorder patients. Archives of General Psychiatry 47, 634-640. (Pubitemid 20215979)
61. Siever LJ, Kalus OF, Keefe RS (1990b). The boundaries of schizophrenia. Psychiatric Clinics of North America 16, 217-244. (Pubitemid 23174751)
62. Smith Y, Bevan MD, Shink E, Bolam P (1998). Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86, 353-387. (Pubitemid 28293917)
63. Sprague RL, White DM, Ullman R, Kalachnik JE (1984). Methods for selecting items in a tardive dyskinesia rating scale. Psychopharmacology Bulletin 20, 339-345. (Pubitemid 14090985)
64. Swartz MS (2008). Introduction to the CATIE Special Section. Psychiatric Services 59, 497-499.
65. Torrey EF, Taylor EH, Bracha HS, Bowler AE, Thomas F, McNell RR, Rawlings PO, Quinn PO, Bigelow LB, Sjostrom K, Higgins ES, Gottesman II (1994). Prenatal origin of schizophrenia in a subgroup of discordant monozygotic twins. Schizophrenia Bulletin 20, 423-432. (Pubitemid 24251254)
66. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L (2009). A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 39, 179-195.
67. Waddington JL, Crow TJ (1988). Abnormal involuntary movements and psychosis in the preneuroleptic era and in unmedicated patients: implications for the concept of tardive dyskinesia. In: Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects (ed. M. Wolf and A. D. Mosnaim), pp. 51-66. Washington, DC: American Psychiatric Press.
68. Walker E, Lewis N, Loewy R, Palyo S (1999). Motor dysfunction and risk for schizophrenia. Developmental Psychopathology 11, 509-523.
69. Walker EF, Neumann LC (1996). Childhood behavioural characteristics and adult brain morphology in schizophrenia. Schizophrenia Research 22, 93-101. (Pubitemid 26394555)
70. Walker EF, Savoie T, Davis D (1994). Neuromotor precursors of schizophrenia. Schizophrenia Bulletin 20, 441-451. (Pubitemid 24251256)
71. Weiner WJ, Rabinstein A, Levin B, Weiner C, Shulman L (2001). Cocaine-induced persistent dyskinesias. Neurology 57, 1525.
72. Welham J, Isohanni M, Jones P, McGrath J (2009a). The antecedents of schizophrenia: a review of birth cohort studies. Schizophrenia Bulletin 35, 603-623.
73. Welham J, Scott J, Williams G, Najman J, Bor W, O'Callaghan M, McGrath J (2009b). Emotional and behavioural antecedents of adults who screen positive for non-affective psychosis: a 21 year birth cohort study. Psychological Medicine 39, 625-634.
74. Woods BT, Kinnery DK, Yurgelun-Todd D (1986). Neurological abnormalities in schizophrenia patients and their families. Archives of General Psychiatry 43, 657-663.
75. Yung AR, Killachey E, Hetrick SE, Parker AG, Schultze-Lutter F, Klosterkoetter R, Purcell R, McGorry PD (2007). The prevention of schizophrenia. International Review of Psychiatry 19, 633-646. (Pubitemid 351185556)